CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Hikma Pharmaceuticals USA INC. recalls Abirtega (abiraterone acetate)…

Hikma Pharmaceuticals USA INC. recalls Abirtega (abiraterone acetate) USP

Read the official FDA notice

Published
28 Oct 2026
Units affected
2136 bottles
Agency
FDA
Country
United States

The hazard

Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12.

Brand / company
Hikma Pharmaceuticals USA INC.
Codes / lots
Lot #: 3047, Exp Date July 2027.
Distribution
Nationwide within the United States
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 28 Oct 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.